Journal of Hepatocellular Carcinoma 2024

6 papers
The 2024 edition of the *Journal of Hepatocellular Carcinoma* emphasizes the optimization of multi-modal treatment strategies and the application of advanced computational tools in oncology. Research themes center on the efficacy and safety of combination therapies, specifically pairing transarterial chemoembolization (TACE) with tyrosine kinase inhibitors and immune checkpoint inhibitors. Comparative studies also evaluate hepatic arterial infusion chemotherapy against TACE for high-risk cases. A notable trend is the integration of machine learning and deep learning to enhance precision medicine. This includes the development of clinical-radiomic fusion models for predicting post-treatment outcomes, such as liver failure, and the use of automated segmentation for radiation therapy planning. Methodologically, the year’s publications frequently employ LASSO regularization for parsimonious clinical prediction and propensity score matching to refine comparative analyses. Prolific contributors such as Guangde Yang, Jiaming Shen, and Baorui Liu have focused on identifying circulating biomarkers for immunotherapeutic response and documenting long-term remission following adjuvant chemotherapy failure. These works reflect a broader movement toward data-driven, personalized approaches in managing unresectable hepatocellular carcinoma.

Top Research Directions

The 3 research directions with Journal of Hepatocellular Carcinoma 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Automated Anatomical Segmentation for Opportunistic Screening116.7%
2Fusing Radiomic Signatures with Clinical Metadata116.7%
3Radiomic Profiling of the Peritumoral Microenvironment116.7%

Download all directions as CSV

About this data

Papers. Journal of Hepatocellular Carcinoma 2024 lists 6 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions. Cite as: Lacuna, “Journal of Hepatocellular Carcinoma 2024”, https://lacuna.tiptreesystems.com/venue/journal-of-hepatocellular-carcinoma/2024.

Top Authors

AuthorPapers
Biqing Huang1
Jiaming Shen1

Papers

Title
Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method
Deep Learning-Based Automatic Segmentation Combined with Radiomics to Predict Post-TACE Liver Failure in HCC Patients
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity S
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoin
Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report